Advances in siRNA Drug Research

(0 User reviews)   219   76

I am Alex Brown. I hold full responsibility for this content, which includes text, images, links, and files. The website administrator and team cannot be held accountable for this content. If there is anything you need to discuss, you can reach out to me via beikrystal25@gmail.com email.
Disclaimer: The domain owner, admin and website staff of Share Research, had no role in the preparation of this post. Share Research, does not accept liability for any loss or damages caused by the use of any links, images, texts, files, or products, nor do we endorse any content posted in this website.

Krystal Beily

Abstract

siRNA, with a molecular weight of about 13 kDa, recruits the RNA-induced silencing complex (RISC) to mRNA through base pairing, thereby inhibiting protein translation. The mRNA is targeted for cleavage through the catalysis of the RISC protein Ago2, a member of the Argonaute family. In addition, other Ago proteins (Ago1, Ago3, and Ago4) catalyze endonuclease-mediated degradation of non-specific mRNA by locating the bound mRNA in processing bodies (P-bodies).

There are no reviews for this Publication.

0
0 out of 5 (0 User reviews )

Add a Review

Your Rating *
There are no comments for this Publication.
You must log in to post a comment.
Log in

Related Publications